Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean tc 02 of pf 04802540 of tc 02?
Displaying drugs 101 - 125 of 206 in total

Magnesium chloride

Magnesium chloride salts are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or sea water.
Approved
Matched Description: … are highly soluble in water and the hydrated form of magnesium chloride can be extracted from brine or …
Matched Mixtures name: … Dextrose 50% Inj W Electrolytes PF Abbovac ... PF İZOLEN DENGELİ ELEKTROLİT İV İNFÜZON İÇİN ÇÖZELTİ, 500 ML SETLİ ... PF İZOLEN DENGELİ ELEKTROLİT İV İNFÜZON İÇİN ÇÖZELTİ, 1000 ML SETLİ …

Glasdegib

Glasdegib, also known as PF-04449913, is a small-molecule hedgehog signaling inhibitor selected under the group of benzimidazoles. In early research, benzimidazoles attracted large interest as they represented a class of inhibitors with low molecular weight, potent inhibitory activity, and lacking unstable functionality. The great lipophilicity of this group of compounds...
Approved
Investigational
Matched Description: … Glasdegib, also known as PF-04449913, is a small-molecule hedgehog signaling inhibitor selected under ... Aberrant of Hh signaling is one of the main pathophysiologies of AML, with observed overexpression or …

Octinoxate

Octinoxate is a cinnamate ester and common ingredient in sunscreen and other skin care products to minimize DNA photodamage. It was originally developed in 1950's as an organic UV-B filter that absorbs UV-B rays from sun. It is often combined with nanoparticles or other water-resistant liposomes in formulations to increase...
Approved
Investigational
Matched Description: … It is often combined with nanoparticles or other water-resistant liposomes in formulations to increase …
Matched Mixtures name: … Rain Or Shine ... TS CC Cream Beige ... TS CC Cream Natural Beige …
Matched Categories: … Compounds used in a research, industrial, or household setting …

Benzalkonium

Benzalkonium is a quaternary ammonium compound used as a biocide, a cationic surfactant, and as a phase transfer agent [FDA Label]. Benzalkonium is more commonly contained in consumer products in its salt form, benzalkonium chloride [FDA Label]. This salt is used in a great variety of international pharmaceutical products such...
Approved
Investigational
Matched Description: … used in a great variety of international pharmaceutical products such as eye, ear, and nasal drops or …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Products: … Trick or Treat Antibacterial Foaming Hand Wash ... PF Anti-bacterial Hand Sanitizing Wipes ... PF Foaming Anti-bacterial Hand Sanitizing …

Menthol

Approved
Matched Products: … Kerasal PF-10 …

Avobenzone

Avobenzone is dibenzoyl methane derivative. It is oil soluble ingredient. Avobenzone has the ability to absorb ultraviolet light over wider range of wavelengths. It is included in many commercially available sunscreens which are used as wide spectrum sunscreens. Avobenzone is very sensitive to light, to increase its stability and duration...
Approved
Investigational
Matched Mixtures name: … City Sunscreen Serum SPF 30 Doctor Ts Super goop ... Neutrogena Wet Skin Kids Applies To Wet Or Dry Skin Sunscreen Stick ... Gradual Self-tanning sunscreen SPF 20 Doctor Ts Supergoop …
Matched Categories: … Compounds used in a research, industrial, or household setting …

M-032

Investigational
Matched Synonyms: … M 032 …
Matched Name: … M-032 …

SNS-032

Investigational
Matched Name: … SNS-032 …

IOWH-032

Iowh032 has been investigated for the treatment of Cholera, Diarrhea, and Secretory Diarrhea.
Investigational
Matched Name: … IOWH-032 …

PF-232798

PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects).
Investigational
Matched Synonyms: … PF-00232798 …
Matched Name: … PF-232798 …
Matched Description: … Oral Dose Of PF-00232798 On QT Intervals In Healthy Subjects). ... PF-232798 is under investigation in clinical trial NCT01140425 (Study To Evaluate The Effect Of A Multiple …

PF-06821497

PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).
Investigational
Matched Name: … PF-06821497 …
Matched Description: … PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory …

PF-04937319

PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics Of Different Formulations Of PF-04937319 In Healthy Subjects).
Investigational
Matched Name: … PF-04937319 …
Matched Description: … Of Different Formulations Of PF-04937319 In Healthy Subjects). ... PF-04937319 is under investigation in clinical trial NCT01513928 (A Study To Compare The Pharmacokinetics …

PF-06650833

PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics of A Modified Release Formulation of PF-06650833 in Healthy Subjects).
Investigational
Matched Name: … PF-06650833 …
Matched Description: … of A Modified Release Formulation of PF-06650833 in Healthy Subjects). ... PF-06650833 is under investigation in clinical trial NCT02609139 (Study to Evaluate Pharmacokinetics …

PF-06282999

Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects).
Investigational
Matched Name: … PF-06282999 …
Matched Description: … And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects). ... Pf 06282999 is under investigation in clinical trial NCT01626976 (A Study To Assess The Safety, Tolerability …

PF-05089771

PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee).
Investigational
Matched Name: … PF-05089771 …
Matched Description: … PF-05089771 In Healthy Subjects And In Subjects With Otseoarthritis Of The Knee). ... PF-05089771 is under investigation in clinical trial NCT01529671 (A Safety And Tolerability Study Of …

PF-06751979

PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults).
Investigational
Matched Name: … PF-06751979 …
Matched Description: … of Multiple Doses PF-06751979 on the Pharmacokinetics of Midazolam in Healthy Adults). ... PF-06751979 is under investigation in clinical trial NCT03126721 (The Study is to Evaluate the Effect …

PF-06882961

PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus).
Investigational
Matched Name: … PF-06882961 …
Matched Description: … and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus). ... PF-06882961 is under investigation in clinical trial NCT03985293 (A 16 Week Study to Evaluate the Efficacy …

PF-04856884

PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination With Axitinib in Patients With Previously Treated Metastatic Renal Cell Carcinoma).
Investigational
Matched Name: … PF-04856884 …
Matched Description: … PF-04856884 or CVX-060 is a selective angiopoietin (Ang)-2 inhibitor. ... [A257291] It is under investigation in clinical trial NCT01441414 (PF-04856884 (CVX-060) in Combination …

PF-04447943

PF-04447943 has been investigated for the treatment of Alzheimer's Disease.
Investigational
Matched Name: … PF-04447943 …
Matched Description: … PF-04447943 has been investigated for the treatment of Alzheimer's Disease. …

PF-03882845

PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type 2 Diabetic Nephropathy.
Investigational
Matched Name: … PF-03882845 …
Matched Description: … PF-03882845 has been used in trials studying the basic science of Diabetes Mellitus, Type 2 and Type …

PF-04958242

PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing Loss, Sensorineural.
Investigational
Matched Name: … PF-04958242 …
Matched Description: … PF-04958242 has been used in trials studying the basic science and treatment of Schizophrenia and Hearing …

PF-00610355

PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease, Asthma, Bronchial, and Bronchial Diseases, among others.
Investigational
Matched Name: … PF-00610355 …
Matched Description: … PF-00610355 has been used in trials studying the treatment of Lung Disease, Moxifloxacin, Pulmonary Disease …

PF-04691502

PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
Investigational
Matched Name: … PF-04691502 …
Matched Description: … PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast …

PF-03635659

Pf03635659 has been used in trials studying the treatment of Chronic Obstructive Pulmonary Disease.
Investigational
Matched Name: … PF-03635659 …

PF-05241328

PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity).
Investigational
Matched Name: … PF-05241328 …
Matched Description: … PF-05241328 is under investigation in clinical trial NCT01165736 (To Calculate the Pharmacokinetics ( …
Displaying drugs 101 - 125 of 206 in total